Titan Medical Inc. (TMD.TO)
CAD 1.13
(2150.0%)
CAD 1.13
(2150.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10.54 Million USD | 124.43% |
| 2022 | -44.03 Million USD | -48.71% |
| 2021 | -29.61 Million USD | -1218.88% |
| 2020 | 2.64 Million USD | 104.32% |
| 2019 | -59.23 Million USD | -6.02% |
| 2018 | -57.73 Million USD | -1012.38% |
| 2017 | -18.86 Million USD | 83.87% |
| 2016 | -27.5 Million USD | 23.4% |
| 2015 | -41.73 Million USD | -187.25% |
| 2014 | -14.17 Million USD | -71.14% |
| 2013 | -8.54 Million USD | -10.23% |
| 2012 | -7.75 Million USD | 50.91% |
| 2011 | -15.79 Million USD | -329.09% |
| 2010 | -3.68 Million USD | -412.12% |
| 2009 | -718.71 Thousand USD | 66.33% |
| 2008 | -2.13 Million USD | -654.43% |
| 2007 | -282.9 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.02 Million USD | -32.64% |
| 2024 Q1 | -740 Thousand USD | 75.05% |
| 2023 FY | - USD | 124.43% |
| 2023 Q2 | 12.78 Million USD | 572.63% |
| 2023 Q4 | 809 Thousand USD | 732.03% |
| 2023 Q1 | -2.7 Million USD | 70.08% |
| 2023 Q3 | -128 Thousand USD | -101.0% |
| 2022 Q1 | -11.92 Million USD | -922.77% |
| 2022 Q3 | -10.37 Million USD | 16.6% |
| 2022 Q4 | -9.03 Million USD | 12.88% |
| 2022 FY | - USD | -48.71% |
| 2022 Q2 | -12.43 Million USD | -4.32% |
| 2021 Q4 | 1.44 Million USD | 107.43% |
| 2021 FY | - USD | -1218.88% |
| 2021 Q3 | -19.51 Million USD | -563.32% |
| 2021 Q1 | -8.6 Million USD | -511.24% |
| 2021 Q2 | -2.94 Million USD | 65.8% |
| 2020 Q2 | 6.11 Million USD | 452.88% |
| 2020 FY | - USD | 104.32% |
| 2020 Q1 | -1.73 Million USD | -123.2% |
| 2020 Q4 | 2.09 Million USD | 154.67% |
| 2020 Q3 | -3.82 Million USD | -162.59% |
| 2019 Q2 | -27.45 Million USD | -378.89% |
| 2019 Q3 | -35.48 Million USD | -29.24% |
| 2019 Q4 | 7.46 Million USD | 121.04% |
| 2019 FY | - USD | -6.02% |
| 2019 Q1 | -5.73 Million USD | 75.37% |
| 2018 FY | - USD | -1012.38% |
| 2018 Q4 | -23.27 Million USD | -59.06% |
| 2018 Q3 | -14.63 Million USD | -37.02% |
| 2018 Q2 | -10.68 Million USD | -16.86% |
| 2018 Q1 | -9.14 Million USD | -406.46% |
| 2017 Q3 | 2.76 Million USD | 139.52% |
| 2017 FY | - USD | 83.87% |
| 2017 Q2 | -6.98 Million USD | -76.97% |
| 2017 Q1 | -3.94 Million USD | -43.06% |
| 2017 Q4 | 2.98 Million USD | 8.02% |
| 2016 Q2 | -9.54 Million USD | 18.98% |
| 2016 Q1 | -11.78 Million USD | 20.0% |
| 2016 Q4 | -2.75 Million USD | 65.87% |
| 2016 Q3 | -8.08 Million USD | 15.32% |
| 2016 FY | - USD | 23.4% |
| 2015 Q4 | -14.72 Million USD | -21.4% |
| 2015 FY | - USD | -187.25% |
| 2015 Q1 | -4.78 Million USD | 45.62% |
| 2015 Q2 | -10.35 Million USD | -116.47% |
| 2015 Q3 | -12.13 Million USD | -17.11% |
| 2014 Q3 | -4.85 Million USD | -1200.49% |
| 2014 Q4 | -8.8 Million USD | -81.3% |
| 2014 Q2 | -373.26 Thousand USD | 37.33% |
| 2014 Q1 | -595.61 Thousand USD | 67.22% |
| 2014 FY | - USD | -71.14% |
| 2013 Q3 | -2.08 Million USD | 5.67% |
| 2013 FY | - USD | -10.23% |
| 2013 Q4 | -1.81 Million USD | 12.84% |
| 2013 Q2 | -2.21 Million USD | 8.7% |
| 2013 Q1 | -2.42 Million USD | -34.98% |
| 2012 Q2 | -1.41 Million USD | 57.34% |
| 2012 Q4 | -1.79 Million USD | -60.37% |
| 2012 Q3 | -1.11 Million USD | 21.19% |
| 2012 Q1 | -3.32 Million USD | 36.21% |
| 2012 FY | - USD | 50.91% |
| 2011 Q1 | -2.17 Million USD | -93.55% |
| 2011 FY | - USD | -329.09% |
| 2011 Q4 | -5.21 Million USD | 10.81% |
| 2011 Q3 | -5.84 Million USD | -102.77% |
| 2011 Q2 | -2.88 Million USD | -32.6% |
| 2010 FY | - USD | -412.12% |
| 2010 Q2 | -948.03 Thousand USD | -82.52% |
| 2010 Q3 | -1.07 Million USD | -13.37% |
| 2010 Q4 | -1.12 Million USD | -4.55% |
| 2010 Q1 | -519.41 Thousand USD | -13.11% |
| 2009 Q1 | -150.82 Thousand USD | -456.67% |
| 2009 FY | - USD | 66.33% |
| 2009 Q4 | -459.23 Thousand USD | -5410.38% |
| 2009 Q3 | 8647.81 USD | 110.6% |
| 2009 Q2 | -81.58 Thousand USD | 45.91% |
| 2008 Q4 | -27.09 Thousand USD | 96.82% |
| 2008 Q2 | -156.67 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 100.0% |
| 2008 FY | - USD | -654.43% |
| 2008 Q3 | -851.57 Thousand USD | -443.53% |
| 2007 Q3 | -4766.32 USD | 0.0% |
| 2007 Q4 | -232.9 Thousand USD | -4786.54% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|